357 related articles for article (PubMed ID: 8375015)
1. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues.
Belinsky M; Jaiswal AK
Cancer Metastasis Rev; 1993 Jun; 12(2):103-17. PubMed ID: 8375015
[TBL] [Abstract][Full Text] [Related]
2. Jun and Fos regulation of NAD(P)H: quinone oxidoreductase gene expression.
Jaiswal AK
Pharmacogenetics; 1994 Feb; 4(1):1-10. PubMed ID: 8004128
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer.
Joseph P; Xie T; Xu Y; Jaiswal AK
Oncol Res; 1994; 6(10-11):525-32. PubMed ID: 7620221
[TBL] [Abstract][Full Text] [Related]
4. An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues.
Gasdaska PY; Fisher H; Powis G
Cancer Res; 1995 Jun; 55(12):2542-7. PubMed ID: 7780966
[TBL] [Abstract][Full Text] [Related]
5. Human antioxidant-response-element-mediated regulation of type 1 NAD(P)H:quinone oxidoreductase gene expression. Effect of sulfhydryl modifying agents.
Li Y; Jaiswal AK
Eur J Biochem; 1994 Nov; 226(1):31-9. PubMed ID: 7957257
[TBL] [Abstract][Full Text] [Related]
6. Regulation of genes encoding NAD(P)H:quinone oxidoreductases.
Jaiswal AK
Free Radic Biol Med; 2000 Aug; 29(3-4):254-62. PubMed ID: 11035254
[TBL] [Abstract][Full Text] [Related]
7. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy.
Begleiter A; Leith MK; Curphey TJ; Doherty GP
Oncol Res; 1997; 9(6-7):371-82. PubMed ID: 9406243
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo.
Sharp SY; Kelland LR; Valenti MR; Brunton LA; Hobbs S; Workman P
Mol Pharmacol; 2000 Nov; 58(5):1146-55. PubMed ID: 11040064
[TBL] [Abstract][Full Text] [Related]
9. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene.
Venugopal R; Jaiswal AK
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14960-5. PubMed ID: 8962164
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.
Traver RD; Horikoshi T; Danenberg KD; Stadlbauer TH; Danenberg PV; Ross D; Gibson NW
Cancer Res; 1992 Feb; 52(4):797-802. PubMed ID: 1737339
[TBL] [Abstract][Full Text] [Related]
11. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
12. Coordinated induction of the c-jun gene with genes encoding quinone oxidoreductases in response to xenobiotics and antioxidants.
Radjendirane V; Jaiswal AK
Biochem Pharmacol; 1999 Aug; 58(4):597-603. PubMed ID: 10413296
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones.
Bailey SM; Suggett N; Walton MI; Workman P
Int J Radiat Oncol Biol Phys; 1992; 22(4):649-53. PubMed ID: 1544832
[TBL] [Abstract][Full Text] [Related]
15. Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity.
Plumb JA; Workman P
Int J Cancer; 1994 Jan; 56(1):134-9. PubMed ID: 8262670
[TBL] [Abstract][Full Text] [Related]
16. High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin.
Cresteil T; Jaiswal AK
Biochem Pharmacol; 1991 Aug; 42(5):1021-7. PubMed ID: 1651729
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of RH1 and related aziridinylbenzoquinones: involvement of activation by NAD(P)H:quinone oxidoreductase (NQO1) and oxidative stress.
Nemeikaite-Ceniene A; Sarlauskas J; Anusevicius Z; Nivinskas H; Cenas N
Arch Biochem Biophys; 2003 Aug; 416(1):110-8. PubMed ID: 12859987
[TBL] [Abstract][Full Text] [Related]
18. Lack of NQO1 induction in human tumor cells is not due to changes in the promoter region of the gene.
Begleiter A; Lange L
Int J Oncol; 2002 Apr; 20(4):835-8. PubMed ID: 11894133
[TBL] [Abstract][Full Text] [Related]
19. ARE- and TRE-mediated regulation of gene expression. Response to xenobiotics and antioxidants.
Xie T; Belinsky M; Xu Y; Jaiswal AK
J Biol Chem; 1995 Mar; 270(12):6894-900. PubMed ID: 7896838
[TBL] [Abstract][Full Text] [Related]
20. Expression of human NAD(P)H: quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: effect on the toxicity of antitumor quinones.
Gustafson DL; Beall HD; Bolton EM; Ross D; Waldren CA
Mol Pharmacol; 1996 Oct; 50(4):728-35. PubMed ID: 8863816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
